Aglaia Oncology Funds
Ernst Geutjes is currently working as an Advisor at Cumulus Oncology, where Ernst evaluates in-licensing opportunities. Ernst also holds positions as a Director at VC Life Foundation, Chief Business Officer at Flindr Therapeutics, Vice President Of Business Development at Genase Therapeutics, Founder of Oncopreneur, and Venture Partner at Aglaia Oncology Funds. Additionally, Ernst has experience as a Board Observer at both Inthera Bioscience and Sapreme Technologies BV. With a background in Biomedical Sciences and extensive experience in venture capital and business development within the oncology field, Ernst Geutjes brings a wealth of knowledge and expertise to the companies Ernst is involved with.
This person is not in any teams
Aglaia Oncology Funds
Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment. For more information, please visit www.aglaia-oncology.com